MedTrace Logo

Study the Effects of Vitamin D and Calcium Supplementation at Tolerable Upper Limit Doses on Calcium Metabolism.

NCT02019381 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 132

Last updated 2016-12-22

No results posted yet for this study

Summary

Recently two distinguished committees, Institute of Medicine (IOM) and The Endocrine Society have proposed different intake guidelines for Calcium and Vitamin D. We wish to compare the effects of both of them on calcium metabolism and bone turnover. We propose a one year randomized double blinded study for the same.

Conditions

  • Delusion of Reference

Interventions

DIETARY_SUPPLEMENT

Endocrine Society UL Dosage Vitamin D

Endocrine Upper limit arm will get 10,000IU Vitamin D and 1200mg Calcium

DIETARY_SUPPLEMENT

Institute of Medicine Dosage Vitamin D

IOM arm will get 600 IU Vitamin D and 1,200 mg Calcium

DIETARY_SUPPLEMENT

Calcium

1200mg of CaCO3 supplementation will be given to each participant in both groups

Sponsors & Collaborators

  • Winthrop University Hospital

    lead OTHER

Principal Investigators

  • John Aloia, MD · Winthrop UH

  • Mageda Mikhail, MD · Winthrop UH

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
90 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02019381 on ClinicalTrials.gov